FSR vs NEO
FSR (FSR) versus NeoGenomics Inc (NEO) — a side-by-side from cached financials, not a winner call.
FSR (FSR) common stock.
NeoGenomics Inc (NEO) is a diagnostics & research company listed on US.
FSR does not have a complete income-statement cache yet.
Latest reported NEO revenue for 2026-06-30 was $388.3M. Net income was -$14.9M. NEO currently screens at market cap $924.0M.
NEO currently screens at market cap $924.0M.
Not investment advice. Open the FSR and NEO stock pages for the full models.
Not investment advice.